Variable | Tested (n = 2,450) | Positive for anti-HEV, N (%) | Pvalue* | OR (95% CI) |
---|---|---|---|---|
Overall prevalence | 2,450 | 144 (5.9) | - | |
Sex | ||||
Male | 994 | 77 (7.8) | 0.001 | 1.0 |
Female | 1,456 | 67 (4.6) | 0.6 (0.4-0.8) | |
Age (years) | ||||
10–19 | 546 | 1 (0.2) | <.0001 | 1.0 |
20–29 | 521 | 6 (1.2) | 6.3 (0.8-52.9) | |
30–39 | 553 | 13 (2.4) | 13.1 (1.7-100.6) | |
40–49 | 557 | 67 (12.0) | 74.5 (10.3-538.5) | |
50–55 | 273 | 57 (20.9) | 143.8 (19.8- >999.9) |